Correction to: The FIDELIO Study Podcast (Diabetes Therapy, (2022), 13, 5, (823-828), 10.1007/s13300-022-01249-5)

Robert Toto; George Bakris

doi:10.1007/s13300-022-01288-y

Correction to: The FIDELIO Study Podcast (Diabetes Therapy, (2022), 13, 5, (823-828), 10.1007/s13300-022-01249-5)

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The original article has published without reference section. The reference is given as ‘‘Bakris GL et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 2020;383(23):2219–29’’.

Original language	English (US)
Journal	Diabetes Therapy
DOIs	https://doi.org/10.1007/s13300-022-01288-y
State	Accepted/In press - 2022
Externally published	Yes

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s13300-022-01288-y

Cite this

@article{ba796dcfd3a14fd6b58f845f40313c42,

title = "Correction to: The FIDELIO Study Podcast (Diabetes Therapy, (2022), 13, 5, (823-828), 10.1007/s13300-022-01249-5)",

abstract = "The original article has published without reference section. The reference is given as {\textquoteleft}{\textquoteleft}Bakris GL et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 2020;383(23):2219–29{\textquoteright}{\textquoteright}.",

author = "Robert Toto and George Bakris",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

doi = "10.1007/s13300-022-01288-y",

language = "English (US)",

journal = "Diabetes Therapy",

issn = "1869-6953",

publisher = "Springer Publishing Company",

}

TY - JOUR

T1 - Correction to

T2 - The FIDELIO Study Podcast (Diabetes Therapy, (2022), 13, 5, (823-828), 10.1007/s13300-022-01249-5)

AU - Toto, Robert

AU - Bakris, George

N1 - Publisher Copyright: © The Author(s) 2022.

PY - 2022

Y1 - 2022

N2 - The original article has published without reference section. The reference is given as ‘‘Bakris GL et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 2020;383(23):2219–29’’.

AB - The original article has published without reference section. The reference is given as ‘‘Bakris GL et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 2020;383(23):2219–29’’.

UR - http://www.scopus.com/inward/record.url?scp=85133284258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133284258&partnerID=8YFLogxK

U2 - 10.1007/s13300-022-01288-y

DO - 10.1007/s13300-022-01288-y

M3 - Comment/debate

C2 - 35780229

AN - SCOPUS:85133284258

SN - 1869-6953

JO - Diabetes Therapy

JF - Diabetes Therapy

ER -

Correction to: The FIDELIO Study Podcast (Diabetes Therapy, (2022), 13, 5, (823-828), 10.1007/s13300-022-01249-5)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this